Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

CRISPR Therapeutics AG. (10/28/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results". Zug & Cambridge, MA.

Organisations Organisation CRISPR Therapeutics AG (Nasdaq: CRSP)
  Group CRISPR Therapeutics (Group)
  Organisation 2 ViaCyte Inc.
  Group ViaCyte (Group)
Products Product CTX001 (CRISPR Therapeutics/Vertex)
  Product 2 CTX110 allogeneic CAR-T cell therapy
Persons Person Kulkarni, Samarth (Sam) (CRISPR Therapeutics 201712– promoted CEO before CBO)
  Person 2 Kim, Susan (CRISPR Therapeutics 201809 Investor Relations)
     


   
Record changed: 2019-11-03

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for CRISPR Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner Bionnale 2021 Digital Event 650x80px




» top